Advertisement

Topics

UGenRA - Genitourinary cancer array - Biotech, Pharma and Life Science Channel

00:22 EST 13th November 2018 | BioPortfolio

UGenRA is a CGI custom-designed oligonucleotide array designed to detect gains and losses of genomic material in endometrial, ovarian, and cervical cancers. Endometrial hyperplasia is a precursor lesion of endometriod endometrial carcinoma (EEC) and since about 50% of women with atypical hyperplasia also have concurrent EEC, it is important to identify those precursor lesions more likely to progress to and those with frank cancer. UGenRATM offers the opportunity to identify such specimens and potentially guide clinical management. Another potential application is to stratify those tumors likely to recur, permitting the identification of patients most likely to benefit from adjuvant therapy. Risk-stratification of stage III/IV ovarian cancer patients after cytoreductive surgery for front-line platinum taxane-based chemotherapy is a potential application for UGenRATM, and the design currently contains the sites of genomic gain/loss with such prognostic value. For any of the three cancers, genomic gain/loss associated with response to particular therapies can be assessed using UGenRATM, especially with the need of only small amounts of starting material and the ability to perform UGenRATM on FFPE specimens.

Source: http://cancergenetics.com/cgi-research/cgh-microarray/  UGenRA is a Registered Trademark of CGI

PubMed Articles [14459 Associated PubMed Articles listed on BioPortfolio]

A Maximum Likelihood Approach for Depth Field Estimation Based on Epipolar Plane Images.

In this paper, a multi-resolution method for depth estimation from dense image arrays is presented. Recent progress in consumer electronics has enabled the development of low cost hand-held plenoptic ...

Screening of Mangifera indica L. functional content using PCA and neural networks (ANN).

A method using reversed-phase high-performance liquid chromatography with diode array detection (HPLC-DAD) was applied after extraction with acidified methanol, to determine 12 bioactive phenolic comp...

Multivariate analysis of the composition of bioactive in tea of the species Camellia sinensis.

This study deals with the development of a separation and quantification method by high performance liquid chromatography with a diode array detector (HPLC- DAD), for the determination of phenolic aci...

Investigation of plasticizer aggregation problem in casein based biopolymer using chemical imaging.

This work aims to investigate the emergence of aggregates caused by redundant plasticizers in the protein matrix of casein based biopolymers using chemical imaging techniques. Near infrared (NIR) imag...

Measuring In Vivo Tissue Metabolism Using C Glucose Infusions in Mice.

Metabolic alterations are a hallmark of cancer. While determining metabolic changes in vitro has delivered valuable insight into the metabolism of cancer cells, it emerges that determining the in vivo...

C Tracer Analysis and Metabolomics in 3D Cultured Cancer Cells.

Metabolomics and C tracer analysis are state-of-the-art techniques that allow determining the concentration of metabolites and the activity of metabolic pathways, respectively. Three dimensional (3D) ...

Measuring the Activation of Cell Death Pathways upon Inhibition of Metabolism.

Nutrient starvation or inhibition of cellular metabolism can induce cancer cell death. This can be measured by a variety of methods. We describe here four simple methods to measure cell death in cultu...

Determining the Impact of Metabolic Nutrients on Autophagy.

Tumorigenesis relies on the ability of cancer cells to obtain necessary nutrients and fulfill increased energy demands associated with rapid proliferation. However, as a result of increased metabolite...

Development of Patient-Derived Tumor Xenograft Models.

In spite of the latest advancements in understanding cancer development and progression, drugs successful in preclinical testing often fail upon reaching phase III clinical trials. A reason for this i...

Methods to Screen Compounds Against Mutant p53 Misfolding and Aggregation for Cancer Therapeutics.

p53 is a critical tumor suppressor that functions as a transcription factor. Mutations in the TP53 gene are observed in more than 50% of cancer cases worldwide. Several of these mutations lead to a le...

News Articles [13340 Associated News Articles listed on BioPortfolio]

Two very interesting new papers in @NatureMedicine today related to cancer #Immunotherapy #Obesity associated with increased efficacy of PD-(L)1 blockade https://www.nature.com/articles/s41591-018-0221-5 … Fecal #microbiome transplantation could he

Two very interesting new papers in @NatureMedicine today related to cancer #Immunotherapy #Obesity associated with increased efficacy of PD-(L)1 blockade https://www.nature.com/articles/s41591-...

Vitamin D, Omega-3s Fail to Prevent Cardiovascular Disease and Cancer

Neither high-dose vitamin D nor omega-3 fatty acid supplements reduce risks for cardiovascular (CV) events or cancer, according to findings presented over the...

Driver, an ambitious startup marketing an app to match cancer patients with clinical trials, has shut down after running out of money just weeks following its high-profile launch. https://buff.ly/2T7uWiz pic.twitter.com/2dDTViIrqI

Driver, an ambitious startup marketing an app to match cancer patients with clinical trials, has shut down after running out of money just weeks following its high-profile launch. https://buff.ly/2T...

Ultrasound finds simple cysts not associated with ovarian cancer risk

Using ultrasound technology, researchers found simple ovarian cysts are not associated with an increased risk of ovarian cancer and do not require additional surveillance or surgical intervention, ...

New Study Looks at Selumetinib for Treating Differentiated Thyroid Cancer

Interim results are in from a study evaluating whether adding selumetinib to RAI improves complete response, irrespective of MAPK pathway alterations.

Erytech Pharma S.A.: ERYTECH Reports Third Quarter 2018 Financial Results and Provides Business Update

Conference call and webcast scheduled for Tuesday, November 13 at 14:30 CET/8:30 am ESTPhase 3 trial for eryaspase in second line pancreatic cancer enrolling patientsPhase 2 trial in triple-negativ...

Study shows novel strategy to reduce breast cancer bone metastasis

Uncovering a novel mechanism that promotes growth of breast cancer bone metastasis has revealed a potential Achilles' heel for these cancer cells. Reported in the journal Cancer Cell, the study shows ...

The Link Between Diet Quality and CRC Outcomes

A study looks at how dietary patterns impact colorectal cancer outcomes before and after diagnosis.

CDS tool improves reader diagnosis of bladder cancer response to treatment

A decision support tool can help physicians better diagnose bladder cancer treatment response on CT, according to an Nov. 10 study published in Academic Radiology.

Report: Cancer clinical trials tech startup Driver shutters two months after launch

The high cost to join the platform – which combined molecular pathology labs with a mobile app – played a role in its low sign-up numbers, CEO says.

Events [0 Results]

None

Companies [799 Associated Companies listed on BioPortfolio]

Bio-Thera Solutions Ltd

Bio-Thera Solutions Ltd, a leading global biotechnology company in Guangzhou, China, is dedicated to researching and developing novel therapeutics for the treatment of cancer, aut...

Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit ...

Brooklyn ImmunoTherapeutics LLC

Brooklyn ImmunoTherapeutics (formerly IRX Therapeutics) is focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, both as a single ag...

Alpha Tau Medical

Founded in 2016, Alpha Tau Medical Ltd. is an Israeli medical device company that focuses on research, development and commercialization of the Alpha DaRT for the treatment of sol...

Alliance for Cancer Gene Therapy

Established in 2001, ACGT is the nation’s only nonprofit dedicated exclusively to funding cell and gene therapy research for all types of cancer. One hundred percent of contr...

Bio-Thera Solutions, Ltd.

Bio-Thera Solutions Ltd, a leading global biotechnology company in Guangzhou, China, is dedicated to researching and developing novel therapeutics for the treatment of cancer, aut...

BioVaxys LLC

BioVaxys LLC, a privately-held, clinical stage biotechnology company that is developing highly-targeted, patient-specific, immunotherapeutic vaccines to treat various solid tumor ...

ImpediMed

Lymphedema is a condition that can cause significant swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is respo...

J. Lohr Vineyards & Wines

J. Lohr Vineyards & Wines was founded in 1972 by Jerry Lohr, who was raised on a South Dakota farm, and has spent six decades actively farming—experience that informs J. Lohr...

Stratify Genomics, Inc.

Currently, there are 35,000 men annually who are unaware of a curable form of clinically significant prostate cancer. Relying solely on family history, 80% of prostate cancer case...

Clinical Trials [8824 Associated Clinical Trials listed on BioPortfolio]

Ceramides in Muscle During Insulin Resistance

Overnutrition and physical inactivity promote the accumulation of sphingolipids such as ceramides which block insulin signaling and anabolic metabolism. Implementation of pharmacological o...

SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer

The purpose of this study is to evaluate the progression-free survival (PFS) of Chemotherapy combined with SHR-1316 in patients with advanced esophageal squamous cell cancer.

Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer

Over the past decade, advances in diagnosis and treatments have dramatically increased the rates of cure for young patients with cancer. As a consequence, a new population of cancer surviv...

Prospective Trial of Digital Breast Tomosynthesis (DBT) in Breast Cancer Screening.

The accuracy of standard two dimension digital mammography (2DDM) in breast cancer screening is limited because of superimposition of normal breast structures onto a two dimensional image....

ONC201 With and Without Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer

This phase II trial studies how well Akt/ERK inhibitor ONC201 (ONC201) with or without methionine-restricted (MR) diet works in treating participants with triple negative breast cancer tha...

Anlotinib in Treatment of Recurrent Small Cell Lung Cancer

Exploring the efficacy and safety of Anlotinib in patients with relapsed small cell lung cancer

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer

The purpose of this study is to evaluate the efficacy and safety (including evaluating side effects) of combination of olaparib and abiraterone versus placebo and abiraterone in patients w...

DS-8201a Compared to Treatment of Physician's Choice for Participants With a Certain Kind of Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

The reason for this trial is to compare DS-8201a to other treatments being used for breast cancer. DS-8201a is a new medicine for breast cancer that has not been approved yet by the Food ...

Tisseel® as a Reinforcement of Esophagojejunal Anastomoses

Background: The dehiscence of esophagojejunal anastomoses is one of the most serious complications after total gastrectomy in patients with gastric cancer. Any method of avoiding this pro...

An Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics, and determine the maximum tolerated dose of ZSP1241 in participants with hepatocellular carcinoma, c...

Videos

None available.

Medical and Biotech [MESH] Definitions

The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.

A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)

A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.

A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.

A contiguous gene syndrome associated with hemizygous deletions of chromosome region 11p13. The condition is marked by the combination of WILMS TUMOR; ANIRIDIA; GENITOURINARY ABNORMALITIES; and MENTAL RETARDATION.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

review and buy UGenRA - Genitourinary cancer array market research data and corporate reports here

Channels Quicklinks